All Dingpei Long articles

  • samson-balogun-8gez-bZO--M-unsplash

    Oral lipid nanoparticle drug can prevent development of colitis-associated cancer


    An oral lipid nanoparticle drug prevents tumor development in mice, suggesting this is a promising drug formulation for preventing colitis-associated cancer, according to a study led by researchers in the Institute for Biomedical Sciences at Georgia State University. The findings published in the journal Pharmaceutics report the ...